Detmer, Felicitas J.
Alpert, Nathaniel M.
Moon, Sung-Hyun
Dhaynaut, Maeva
Guerrero, J. Luis
Guehl, Nicolas J.
Xing, Fangxu
Brugarolas, Pedro
Shoup, Timothy M.
Normandin, Marc D.
Pelletier-Galarneau, Matthieu
El Fakhri, Georges
Petibon, Yoann
Funding for this research was provided by:
National Institutes of Health (P41EB022544, P41EB022544, P41EB022544, P41EB022544, P41EB022544, P41EB022544, P41EB022544, P41EB022544, P41EB022544, P41EB022544, P41EB022544, P41EB022544, P41EB022544)
Article History
Received: 15 December 2021
Accepted: 8 March 2022
First Online: 12 April 2022
Competing interests
: Patent US 11,109,819 B2, ‘System and method for quantitatively mapping mitochondrial membrane potential’ (status: granted) is assigned to The General Hospital Corporation and lists Drs. Alpert, El Fakhri, Guehl and Normandin as inventors. The other authors declare that they have no potential conflict of interest.